Drilldown: Medicines
Appearance
Medicines > classes
:
Analgesic
or
Benzodiazepine
or
[[:Category:Psychostimulants|Psychostimulant]] (atypical) 
:
Analgesic
or
Benzodiazepine
or
[[:Category:Psychostimulants|Psychostimulant]] (atypical) 
Use the filters below to narrow your results.
Alprazolam (1) ·
Bromazepam (1) ·
Butorphanol (1) ·
Chlordiazepoxide (1) ·
Clobazam (1) ·
Clonazolam (1) ·
Clorazepate (1) ·
Codeine (2) ·
Dextropropoxyphene (1) ·
Diclazepam (1) ·
Dihydrocodeine (1) ·
Estazolam (1) ·
Ethylmorphine (1) ·
Fentanyl (1) ·
Flualprazolam (1) ·
Flubromazepam (1) ·
Flubromazolam (1) ·
Flunitrazepam (1) ·
Flunitrazolam (1) ·
Flurazepam (1) ·
Hydrocodone (1) ·
Hydromorphone (1) ·
Levorphanol (1) ·
Lormetazepam (1) ·
Meperidine (1) ·
Midazolam (1) ·
Modafinil (1) ·
Nalbuphine (1) ·
Nifoxipam (1) ·
Nitrazepam (1) ·
Oxazepam (1) ·
Oxymorphone (1) ·
Papaverine (1) ·
Pentazocine (1) ·
Pyrazolam (1) ·
Quazepam (1) ·
Tapentadol (1) ·
Temazepam (1) ·
Triazolam (1)
None (14) ·
(multiple, generic dominant) (1) ·
Dalmane (1) ·
Darvon (1) ·
Demerol (1) ·
Dilaudid (1) ·
Doral (1) ·
Duragesic (1) ·
Halcion (1) ·
Lexotan (1) ·
Librium (1) ·
Mogadon (1) ·
Nubain (1) ·
Nucynta (1) ·
Onfi (1) ·
Opana (1) ·
ProSom (1) ·
Provigil (Teva/Cephalon); Alertec (Canada); Modavigil (Australia) (1) ·
Restoril (1) ·
Rohypnol (1) ·
Serax (1) ·
Stadol (1) ·
Talwin (1) ·
Tranxene (1) ·
Versed (1) ·
Vicodin (1) ·
Xanax (1)
None (1) ·
Extremely potent GABAA positive allosteric modulator (1) ·
GABA-A positive allosteric modulator'"`UNIQ--ref-00000067-QINU`"' '"`UNIQ--vote-00000068-QINU`"' (1) ·
GABAA positive allosteric modulator (18) ·
GABAA positive allosteric modulator; low sedation (1) ·
GABAA positive allosteric modulator; prodrug of desmethyldiazepam (1) ·
GABAA positive allosteric modulator; very long half-life (1) ·
Kappa agonist; mu antagonist (1) ·
Kappa agonist; mu partial agonist (1) ·
Kappa agonist; mu partial agonist/antagonist (1) ·
Mu-opioid agonist; norepinephrine reuptake inhibitor (1) ·
Mu-opioid receptor agonist (4) ·
Mu-opioid receptor agonist; prodrug (metabolized to morphine) (1) ·
Mu-opioid receptor agonist; sodium channel blocker (1) ·
Mu/kappa/delta agonist; NMDA antagonist (1) ·
Phosphodiesterase inhibitor; calcium channel blocker (1) ·
Potent mu-opioid receptor agonist (3) ·
Prodrug; converted to [[Morphine|morphine]] by [[Enzyme:CYP2D6|CYP2D6]] for analgesic action. (1)
None (37) ·
0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) ·
Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1) ·
Tablets: 100 mg, 200 mg (scored). [[Armodafinil]] (Nuvigil), the R-enantiomer of modafinil, is available separately as 50 mg, 150 mg, 200 mg, and 250 mg tablets. (1)
None (37) ·
30-60 min (immediate-release); 1-2 h (extended-release) (1) ·
30–60 min (PO) (1) ·
Peak plasma concentration in 2-4 hours after oral administration. Clinically perceptible wakefulness-promoting effects typically begin within 1-2 hours of dosing.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
None (37) ·
4–6 hours (1) ·
6 h (immediate-release); ~11 h (extended-release) (1) ·
Effective duration approximately 12-15 hours at the 200 mg dose, consistent with the elimination half-life. A single morning dose generally sustains wakefulness throughout the day without substantially disrupting nighttime sleep onset when taken early.'"`UNIQ--ref-0000006D-QINU`"' (1)
None (37) ·
80-90% oral (1) ·
Oral bioavailability is not precisely established in the label but absorption is rapid and essentially complete. Food delays peak plasma concentration by approximately one hour but does not reduce the extent of absorption.'"`UNIQ--ref-0000006F-QINU`"' (1) ·
~50% (variable, CYP2D6-dependent for analgesic effect). (1)
Showing below up to 40 results in range #1 to #40.

